Sara Marcó

1.1k total citations
14 papers, 580 citations indexed

About

Sara Marcó is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Sara Marcó has authored 14 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Sara Marcó's work include Lysosomal Storage Disorders Research (11 papers), Virus-based gene therapy research (4 papers) and Trypanosoma species research and implications (4 papers). Sara Marcó is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Virus-based gene therapy research (4 papers) and Trypanosoma species research and implications (4 papers). Sara Marcó collaborates with scholars based in Spain, France and United States. Sara Marcó's co-authors include Fátima Bosch, Virginia Haurigot, Miquel García, Albert Ribera, Pilar Villacampa, Jesús Ruberte, Eduard Ayuso, Albert Ruzo, Sandra Motas and Federico Mingozzi and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.

In The Last Decade

Sara Marcó

14 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Marcó Spain	11	368	240	239	148	124	14	580
Michaël Hocquemiller France	12	253 0.7×	268 1.1×	365 1.5×	102 0.7×	123 1.0×	17	642
Sandra Motas Spain	6	215 0.6×	146 0.6×	150 0.6×	94 0.6×	77 0.6×	6	359
Aaron S. Meadows United States	11	176 0.5×	178 0.7×	189 0.8×	86 0.6×	51 0.4×	13	383
Luca Maggioni Spain	5	168 0.5×	156 0.7×	141 0.6×	77 0.5×	53 0.4×	7	321
Susanna Lualdi Italy	19	371 1.0×	90 0.4×	376 1.6×	153 1.0×	106 0.9×	25	690
Aiyin Liao United Kingdom	8	270 0.7×	63 0.3×	149 0.6×	80 0.5×	119 1.0×	14	376
Darren Murrey United States	11	133 0.4×	105 0.4×	226 0.9×	43 0.3×	49 0.4×	13	351
Kerry O. Cresawn United States	8	208 0.6×	136 0.6×	241 1.0×	67 0.5×	134 1.1×	9	438
Ashley N. Randle United States	11	218 0.6×	148 0.6×	187 0.8×	86 0.6×	89 0.7×	17	365
Martina Cesani Italy	12	220 0.6×	169 0.7×	290 1.2×	107 0.7×	52 0.4×	12	540

Countries citing papers authored by Sara Marcó

Since Specialization

Citations

This map shows the geographic impact of Sara Marcó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Marcó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Marcó more than expected).

Fields of papers citing papers by Sara Marcó

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Marcó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Marcó. The network helps show where Sara Marcó may publish in the future.

Co-authorship network of co-authors of Sara Marcó

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Marcó. A scholar is included among the top collaborators of Sara Marcó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Marcó. Sara Marcó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Marcó, Sara, Sergio Muñoz, Fátima Bosch, & Verónica Jiménez. (2025). Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches. Mammalian Genome. 36(2). 488–499. 1 indexed citations

Casana, Estefanía, Verónica Jiménez, Claudia Jambrina, et al.. (2022). AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity. Molecular Therapy — Methods & Clinical Development. 25. 190–204. 19 indexed citations

Marcó, Sara, et al.. (2021). New correlations between ocular parameters and disease severity in Spanish patients with Gaucher’s disease Type I. PLoS ONE. 16(12). e0260241–e0260241. 2 indexed citations

Marcó, Sara, Virginia Haurigot, Albert Ribera, et al.. (2021). Seven-year follow-up of durability and safety of AAV CNS gene therapy for a lysosomal storage disorder in a large animal. Molecular Therapy — Methods & Clinical Development. 23. 370–389. 24 indexed citations

Ribera, Albert, Miquel García, Anna Pujol, et al.. (2021). Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy. Nature Communications. 12(1). 5343–5343. 23 indexed citations

Marcó, Sara, Virginia Haurigot, & Fátima Bosch. (2019). In Vivo Gene Therapy for Mucopolysaccharidosis Type III (Sanfilippo Syndrome): A New Treatment Horizon. Human Gene Therapy. 30(10). 1211–1221. 23 indexed citations

Roca, Carles, Sandra Motas, Sara Marcó, et al.. (2017). Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID. Human Molecular Genetics. 26(8). 1535–1551. 43 indexed citations

Motas, Sandra, Virginia Haurigot, Miquel García, et al.. (2016). CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome). JCI Insight. 1(9). e86696–e86696. 56 indexed citations

Marcó, Sara, Anna Pujol, Carles Roca, et al.. (2016). Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC. Disease Models & Mechanisms. 9(9). 999–1013. 18 indexed citations

10.

Ribera, Albert, Virginia Haurigot, Miquel García, et al.. (2014). Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy. Human Molecular Genetics. 24(7). 2078–2095. 46 indexed citations

11.

Mallio, Carlo Augusto, et al.. (2014). Bilateral remote cerebellar haemorrhage after spinal surgery: A case study and review of the literature. Brain Injury. 28(9). 1216–1222. 7 indexed citations

12.

Haurigot, Virginia, Sara Marcó, Albert Ribera, et al.. (2013). Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy. Journal of Clinical Investigation. 123(8). 3254–3271. 176 indexed citations

13.

Ruzo, Albert, Sara Marcó, Miquel García, et al.. (2012). Correction of Pathological Accumulation of Glycosaminoglycans in Central Nervous System and Peripheral Tissues of MPSIIIA Mice Through Systemic AAV9 Gene Transfer. Human Gene Therapy. 23(12). 1237–1246. 97 indexed citations

14.

Ruzo, Albert, Miquel García, Albert Ribera, et al.. (2011). Liver Production of Sulfamidase Reverses Peripheral and Ameliorates CNS Pathology in Mucopolysaccharidosis IIIA Mice. Molecular Therapy. 20(2). 254–266. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact